陈一川 林朝柱 李开芳 柯蔓萍 吴 哲 程家靖 陈桂芬
(毕节市中医院,贵州 毕节,551700)
中图分类号:R259.6 文献标识码:A 文章编号:1674-7860(2015)21-0023-03
【摘 要】目的:探讨宣肺脱敏方治疗咳嗽变异性哮喘(CVA)临床疗效。方法:选取我院收治的60例咳嗽变异性哮喘患者为研究对象,随机分为治疗组和对照组,对照组30例采用吲哚美辛肠溶片和马来酸氯苯那敏片治疗,治疗组30例采用宣肺脱敏方治疗,统计3 d缓解率。结果:两组患者治疗3 d后,治疗组缓解率高达93.3%,对照组为76.7%,两组对比差异显著(P<0.05),具有统计学意义。结论:宣肺脱敏方治疗咳嗽变异性哮喘起效快,效果确切,可以大力推广应用。
【关键词】宣肺脱敏方;咳嗽变异性哮喘;疗效
【Abstract】Objective:To explore the clinical curative effect of Releasing lung and Desensitization Formula on treatment of cough variant asthma (CVA) .Methods:60 cases of cough variant asthma patients in our hospital were selected as the research objects. They were randomly divided into treatment group and control group.30 patients in the control group were treated by indomethacin enteric coatel tablets and chlorphenamine maleate. 30 patients in the treatment group were treated by Releasing lung and Desensitization Formula.The remission rate of 3 days were calculated. Results: Three days after the treatment,the remission rate of the treatment group was as high as 93.3% and the control group was 76.7%.There was significant difference between the two groups (P<0.05).Conclusion: The effect of Releasing Lung Desensitization Formula on CVA is fast and exact, so it can be largely promoted.
【Keywords】Releasing Lungs and Desensitization Formula;Cough Variant Asthma;Curative Effect
doi:10.3969/j.issn.1674-7860.2015.21.011
详情可登录【万方数据】
也可登录【中国知网】